CurveBeam AI Ltd (ASX: CVB) Share Price and News

Price

Movement

( )

(20 mins delayed)

52 Week Range

-

 
1 Year Return

 

CurveBeam AI Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $35.26 million
P/E Ratio N/A
Dividend Yield 0.00%
Shares Outstanding 389.80 million
Earnings per share -0.078
Dividend per share N/A
Year To Date Return -11.11%
Earnings Yield N/A
Franking -
Share Price

Day Change

( )

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

CurveBeam AI Ltd (ASX: CVB)
Latest News

A man in suit and tie is smug about his suitcase bursting with cash.
Small Cap Shares

Bell Potter is tipping huge returns from these small cap ASX shares

Big things could come from these small caps in 2024.

Read more »

CVB ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size

About CurveBeam AI Ltd

CurveBeam AI Ltd is a manufacturer of specialized imaging equipment that has developed software that, through the use of artificial intelligence (AI), and deep learning AI (DLAI), automates the scan processing and analysis of the high-quality images produced from the company's CT devices to assist in the clinical assessment. The company has one operating segment, being the research, design, manufacture and sale of cone beam CT imaging equipment for orthopaedic specialties, which includes the development, validation and preparation for commercialisation of a HRpQCT Medical Device and Software as a Service (SaaS) platform.

CVB Share Price History Data provided by Morningstar.

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
22 Jan 2025 $0.12 $-0.01 -8.00% 138,744 $0.13 $0.13 $0.12
21 Jan 2025 $0.13 $-0.01 -7.69% 619,345 $0.13 $0.13 $0.12
20 Jan 2025 $0.13 $0.00 0.00% 10,369 $0.13 $0.13 $0.13
17 Jan 2025 $0.13 $0.00 0.00% 38,557 $0.13 $0.13 $0.13
16 Jan 2025 $0.13 $-0.01 -7.41% 24,808 $0.13 $0.13 $0.13
15 Jan 2025 $0.14 $0.01 8.00% 15,000 $0.14 $0.14 $0.14
14 Jan 2025 $0.13 $-0.02 -14.29% 272,515 $0.14 $0.14 $0.13
13 Jan 2025 $0.14 $0.01 7.41% 22,674 $0.14 $0.14 $0.14
10 Jan 2025 $0.14 $0.01 7.69% 59,058 $0.13 $0.14 $0.13
09 Jan 2025 $0.13 $-0.01 -7.41% 456,208 $0.14 $0.14 $0.13
08 Jan 2025 $0.14 $0.00 0.00% 240,238 $0.14 $0.14 $0.13
07 Jan 2025 $0.14 $-0.01 -6.90% 20,555 $0.15 $0.15 $0.14
06 Jan 2025 $0.15 $-0.01 -6.45% 415,883 $0.16 $0.16 $0.15
03 Jan 2025 $0.16 $0.02 14.29% 577,485 $0.15 $0.16 $0.15
02 Jan 2025 $0.14 $0.01 7.41% 210,927 $0.15 $0.15 $0.13
31 Dec 2024 $0.14 $0.03 27.27% 46,406 $0.12 $0.14 $0.12
30 Dec 2024 $0.11 $-0.01 -8.70% 73,399 $0.12 $0.12 $0.11
27 Dec 2024 $0.12 $0.01 9.09% 21,253 $0.11 $0.12 $0.11
24 Dec 2024 $0.11 $0.00 0.00% 28,472 $0.11 $0.11 $0.11

Director Transactions Data provided by Morningstar.

Data provided by Morningstar.
Date Director Type Amount Value Notes
13 Dec 2024 Kate Robb Issued 383,508 $74,937
Director remuneration. VWAP
13 Dec 2024 Kate Robb Issued 31,423 $5,656
Employee Share Ownership Plan/Directors Salary Sacrifice.
13 Dec 2024 Robert Lilley Issued 255,672 $50,009
Director remuneration. 273,902 Rights VWAP
13 Dec 2024 Robert Lilley Issued 105,430 $18,977
Employee Share Ownership Plan/Directors Salary Sacrifice.
13 Dec 2024 Robert Lilley Issued 85,937 $10,742
Conversion of securities.
13 Dec 2024 Robert Lilley Exercise 85,937 $10,742
Conversion of securities. 18,230 Rights
13 Dec 2024 Arun Singh Issued 1,409,032 $436,799
Director remuneration.
13 Dec 2024 Arun Singh Issued 131,237 $23,622
Issue of securities. 400,077 Rights
13 Dec 2024 Arun Singh Issued 311,020 $55,983
Employee Share Ownership Plan/Directors Salary Sacrifice.
13 Dec 2024 Hashan Silva Issued 383,508 $74,937
Director remuneration. vwap
13 Dec 2024 Hashan Silva Issued 31,423 $5,656
Employee Share Ownership Plan/Directors Salary Sacrifice.
06 Dec 2024 Robert Lilley Buy 250,000 $29,825
On-market trade.
28 Nov 2024 Hashan Silva Buy 26,454 $2,936
On-market trade.
27 Nov 2024 Kate Robb Buy 25,000 $2,750
On-market trade.
31 Oct 2024 Hashan Silva Issued 11,111,111 $1,999,999
Placement.
16 Oct 2024 Arun Singh Buy 744,132 $107,957
As advised by the company. Contingent Merger Consideration, US$
16 Oct 2024 Arun Singh Buy 332,280 $48,206
As advised by the company. Contingent Merger Consideration,usd$
13 Feb 2024 Hashan Silva Issued 109,375 $52,500
Director remuneration.
13 Feb 2024 Kate Robb Issued 109,375 $52,500
Director remuneration.
13 Feb 2024 Robert Lilley Issued 72,917 $35,000
Director remuneration. 104,167 share rights
13 Feb 2024 Arun Singh Issued 268,840 $107,804
Issue of securities. vwap, 268,840 Share Rights

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Ms Kate Robb Non-Executive Director Apr 2023
Ms Robb has over 25 years of finance, governance, risk management and compliance experience. Ms Robb previously served as a non-executive director and chair of the audit committee of unlisted public company Sandringham Community Financial Services Ltd, a Bendigo Bank Community Bank. She is Chair of the Risk Committee.
Mr Robert Lilley Non-Executive ChairmanNon-Executive Director Apr 2021
Mr Lilley has over 35 years of experience in the medical device and diagnostics industries. Mr Lilley previously served as senior vice president of global sales and marketing for Digene Corporation, a molecular diagnostics company, which was subsequently acquired by Qiagen N.V. He is a member of the Risk Committee.
Mr Arun Singh Chief Operating OfficerChief Technology OfficerExecutive DirectorPresident Mar 2023
Mr Singh has over 34 years of experience in the advanced imaging technology industry, with a focus on medical imaging. Since 2009, he has served as President and Chief Executive Officer of CurveBeam US, prior to which Mr Singh co-founded and served as the Vice President and Chief Technology Officer of Imaging Sciences International Inc. (ISI), which was subsequently acquired by Danaher Corporation.
Mr Hashan De Silva Non-Executive Director Oct 2021
Mr Silva is an experienced sell side and buy side investor in the Australian healthcare sector. Previously he held roles such as the head of healthcare research at Karst Peak, an investment management firm based in Sydney and Hong Kong, which has a focus on biotechnology, health technology, medical devices and diagnostics. He is a member of the Risk Committee.

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
HSBC Custody Nominees (Australia) Limited 67,419,801 18.50%
Citicorp Nominees Pty Limited 46,739,868 12.83%
KP TMF ASA 2 \C 21,857,867 6.00%
Arun Singh 20,561,672 5.64%
HSBC Custody Nominees (Australia) Limited A/C 2 12,577,575 3.45%
Gregory Wayne Brown 11,048,024 3.03%
Susmita Singh Arun Singh Family A/C> 10,444,231 2.87%
Arun Singh Arun Singh Family A/C> 9,034,709 2.48%
UBS Nominees Pty Ltd 6,661,601 1.83%
J P Morgan Nominees Australia Pty Limited 6,023,194 1.65%
Capital M Group Ii Llc 4,891,426 1.34%
Apex Fund Services Pty Ltd Frazis Venture Fund A/C> 4,621,452 1.27%
Gregory Wayne Brown G W Brown Sf A/C> 4,542,500 1.25%
Seego Pty Ltd 4,094,528 1.12%
Ilwella Pty Ltd 3,405,102 0.93%
Uwe Mundry and Sigrid Mundry Uwe Sigrid Mundry Rev A/C> 3,370,593 0.93%
UM Commercialisation Pty Ltd 3,260,000 0.89%
BNP Paribas Noms Pty Ltd 3,070,707 0.84%
Robert Mcg Lilley Robert Mcg Lilley A/C> 2,902,217 0.80%
Francois Lintz 2,865,040 0.79%

Profile

since

Note